Pilot Multilevel Intervention Among Transgender Women Living With HIV in Santo Domingo
Conditions: HIV Interventions: Behavioral: Gender Affirming Abriendo Puertas (GAP) Sponsors: University of North Carolina, Chapel Hill; Instituto Dermatol ógico y Cirugía de Piel (IDCP); George Washington University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Cross-condition Validation of the Steroid PRO
Conditions: Inflammatory Disease; Immune System Disorder; Gastrointestinal Diseases; Dermatologic Disease; Respiratory Disease Interventions: Other: Cognitive Interview Sponsors: University of the West of England; Johns Hopkins University; University of Pittsburgh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Promoting Viral Suppression Among Transgender Women Living With HIV in Santo Domingo
Conditions: HIV Interventions: Behavioral: Gender Affirming Abriendo Puertas (Opening Doors) (GAP) Sponsors: University of North Carolina, Chapel Hill; Instituto Dermatol ógico y Cirugía de Piel (IDCP); George Washington University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Pivotal Study to Evaluate the Efficacy and Safety of Injection With LASBEAU Strong in Correction of Nasolabial Folds
Conditions: Dermal Fillers Interventions: Device: LASBEAU Strong or Restylane Lyft injection as hyaluronic acid fillers Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
National Register of Moderate and Severe Adult Atopic Dermatitis
Conditions: Atopic Dermatitis Sponsors: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: Tralokinumab + TCS; Drug: Placebo + TCS Sponsors: LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Phase IIa Trial Investigating the Safety, Tolerability, Pharmacokinetics and Efficacy of Topical Ointment YR001 in Adult Patients With Mild to Moderate Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: YR001 ointment Sponsors: Hangzhou Yirui Pharmaceutical Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma Sponsors: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: YR001 ointment; Other: Placebo Sponsors: Hangzhou Yirui Pharmaceutical Technology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
The efficacy and safety of deucravacitinib compared to methotrexate, in patients with vulvar lichen planus who have failed topical therapy with potent corticosteroids: a study protocol for a single-centre double-blinded randomised controlled trial
DiscussionHigh-quality evidence guiding the management of women with VLP is lacking. Once completed, this will be the first double-blinded RCT to compare systemic treatments in VLP. The results of this study will provide valuable, high-quality data to guide second-line therapy options for VLP that is recalcitrant to potent topical corticosteroids.Trial registrationAustralian New Zealand Clinical Trials Registry ACTRN12623000682640. Registered on 26 June 2023. (Source: Trials)
Source: Trials - March 12, 2024 Category: Research Source Type: clinical trials
More Than Two-Thirds of People with Atopic Dermatitis and Skin of Color Experienced Skin Improvement in a First-of-its-Kind Lebrikizumab Study
INDIANAPOLIS, March 10, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color and moderate-to-severe atopic dermatitis, commonly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 10, 2024 Category: Pharmaceuticals Source Type: clinical trials
Acellular Dermal Matrix Versus Tenting Technique in Peri-implant Soft Tissue Augmentation and Crestal Bone Stability
Conditions: Soft Tissue Augmentation Interventions: Procedure: Acellular Dermal Matrix; Procedure: Soft Tissue Expansion using Tenting Technique Sponsors: Harvard Medical School (HMS and HSDM) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
Conditions: Atopic Dermatitis; Food Allergy; Healthy Interventions: Other: Data and biospecimen collection; Other: Skin biopsies; Other: Oral Food Challenge (OFC) procedures Sponsors: University of Michigan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Effect of Vitamin D Injection on Hypertrophic Scars and Keloids
Conditions: Dermatologic Disease Interventions: Drug: Cholecalciferol Sponsors: Mostafa Bahaa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Conditions: Dermatomyositis Interventions: Biological: KYV-101 Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
